<DOC>
	<DOCNO>NCT00839254</DOCNO>
	<brief_summary>The aim study ass effectiveness GSK Biologicals ' pneumococcal conjugate vaccine ( GSK1024850A ) prevent invasive disease cause S. pneumoniae H. influenzae reduce occurrence hospital-diagnosed pneumonia case , tympanostomy tube placement outpatient antimicrobial prescription child start vaccination 18 month age . These data collect national register analyze combination data collect subject enrol large scale cluster-randomized study 111442 . The study also assess immune response GSK1024850A vaccine impact vaccine occurrence acute otitis medium , carriage , safety child start vaccination 18 month age .</brief_summary>
	<brief_title>Impact Carriage , Acute Otitis Media , Immuno &amp; Safety GSK Biologicals ' Pneumococcal Conjugate Vaccine 1024850A</brief_title>
	<detailed_description>The protocol post updated regard outcome measure follow Protocol amendment 4 , 12 August 2011 .</detailed_description>
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Streptococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Subjects investigator believe parent ( ) /guardian ( ) comply requirement protocol enrol study . Male female , include , 6 week 18 month age time first vaccination . Written inform consent obtain parent ( ) guardian ( ) subject . Use investigational nonregistered product ( drug vaccine ) within 30 day precede first dose study vaccine , plan use vaccine ( ) study vaccine ( ) entire study period . Previous vaccination register , nonregistered investigational pneumococcal vaccine , plan use vaccine study vaccine study period . If child belongs high risk group pneumococcal infection ( child anatomic functional asplenia , HIV infection , chronic cardiac respiratory disease ( asthma ) , diabetes , cochlear implant , CSF fistula significant immunodeficiency ) license pneumococcal conjugate vaccine make locally available , subject enrol study refer specific immunization program . Previous vaccination Hepatitis B virus register , nonregistered investigational vaccine , plan use vaccine study vaccine study period . Previous vaccination Hepatitis A virus register , nonregistered investigational vaccine , plan use vaccine study vaccine study period . Known severe hypersensitivity component study vaccine , include neomycin . Any medical condition would contraindicate initiation routine immunization outside clinical trial context .</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>18 Months</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Streptococcus pneumoniae</keyword>
	<keyword>acute otitis medium</keyword>
	<keyword>Pneumococcal conjugate vaccine</keyword>
	<keyword>nasopharyngeal carriage</keyword>
	<keyword>Haemophilus influenzae</keyword>
	<keyword>immunogenicity</keyword>
	<keyword>invasive disease</keyword>
</DOC>